Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Identification of microRNAs that regulate DNA damage repair

EF 2009-10

Résumé
Resistance to DNA damaging agents used in chemotherapy and radiotherapy is a major problem in cancer treatment. Mammalian cells have developed an elaborate DNA damage response (DDR) system and DNA repair machinery, which play a critical role in development of resistance to DNA damaging agents in cancer cells. Key components of DDR, such as H2AX, 53BP1, BRCA1 and FANCD2, accumulate, form DNA damage-induced nuclear foci, and regulate repair at sites of DNA damage. Formation of these nuclear foci is therefore a good marker of DDR pathway integrity. Precise regulation of DDR pathways is crucial for cell survival and its abrogation often results in genetic instability. MicroRNAs (miRNAs) are short, non-coding RNA molecules that negatively regulate gene expression. Some miRNAs function as oncogenes or tumor suppressors. However, the role of miRNAs in DDR is largely unknown. By screening a human miRNA mimics library I have identified 8, 10, 20 and 15 miRNA mimics that decrease nuclear foci formation of H2AX, 53BP1, BRCA1 and FANCD2, respectively. Based on this preliminary study, I hypothesize that DDR and DNA repair pathways are regulated by miRNAs. To test it, I will first validate these miRNAs individually in response to various DNA damaging agents in multiple cancer and normal cell lines. I will also demonstrate how these validated miRNAs modulate DNA repair by identifying their direct targets. I will then examine the biological significance of validated miRNAs in DNA repair assays and DNA damage sensitivity assays, and determine whether miRNA-mediated inactivation of DNA repair pathways is functionally relevant in cancer. This study will identify miRNAs that regulate DDR and DNA repair pathways and provide new insights into the regulation of DDR and DNA repair. Understanding of these regulations will further clarify the pathogenesis of cancer and the mechanism of resistance to DNA damaging agents and may eventually lead to new approaches for defeating cancer.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Washington, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
193049
Name
Wang Yemin
Region
Washington
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification of microRNAs that regulate DNA damage repair
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell Cycle Analysis; Chemosensitivity; Dna Damage Response; Dna Repair; Genome Instability; Immunofluorescent Staining; Microrna; Nuclear Repair Foci; Radiosensitivity; Western Blot
Abstract
Resistance to DNA damaging agents used in chemotherapy and radiotherapy is a major problem in cancer treatment. Mammalian cells have developed an elaborate DNA damage response (DDR) system and DNA repair machinery, which play a critical role in development of resistance to DNA damaging agents in cancer cells. Key components of DDR, such as H2AX, 53BP1, BRCA1 and FANCD2, accumulate, form DNA damage-induced nuclear foci, and regulate repair at sites of DNA damage. Formation of these nuclear foci is therefore a good marker of DDR pathway integrity. Precise regulation of DDR pathways is crucial for cell survival and its abrogation often results in genetic instability. MicroRNAs (miRNAs) are short, non-coding RNA molecules that negatively regulate gene expression. Some miRNAs function as oncogenes or tumor suppressors. However, the role of miRNAs in DDR is largely unknown. By screening a human miRNA mimics library I have identified 8, 10, 20 and 15 miRNA mimics that decrease nuclear foci formation of H2AX, 53BP1, BRCA1 and FANCD2, respectively. Based on this preliminary study, I hypothesize that DDR and DNA repair pathways are regulated by miRNAs. To test it, I will first validate these miRNAs individually in response to various DNA damaging agents in multiple cancer and normal cell lines. I will also demonstrate how these validated miRNAs modulate DNA repair by identifying their direct targets. I will then examine the biological significance of validated miRNAs in DNA repair assays and DNA damage sensitivity assays, and determine whether miRNA-mediated inactivation of DNA repair pathways is functionally relevant in cancer. This study will identify miRNAs that regulate DDR and DNA repair pathways and provide new insights into the regulation of DDR and DNA repair. Understanding of these regulations will further clarify the pathogenesis of cancer and the mechanism of resistance to DNA damaging agents and may eventually lead to new approaches for defeating cancer.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wang, Yemin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~